Tyr'd and True: Immunochemical reagents and kits for studying tyrosine phosphorylation

Tyrosine Phosphorylantion State-Sensitive Antibodies Protein tyrosine kinases (PTKs) are a diverse lot, including both transmembrane and soluble cytoplasmic enzymes. Roughly 10 percent of a cell's proteins are subject to covalent modification via phosphorylation, but tyrosine (Tyr) residues are modified in only about one out of every 100 protein phosphorylation events. When Tyr-phosphorylation occurs, cells pay heed. PTKs play vital roles in a wide variety of cellular processes, including gro

Written byDeborah Wilkinson
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share


If you are in the business of detecting, visualizing, or purifying Tyr-phosphorylated proteins, then antiphosphotyrosine antibodies [ anti-(P)Tyrs] will definitely be on your shopping list. Several types of anti-(P)Tyrs are commercially available. Polyclonal preparations are sold by various vendors, and a number of different monoclonal anti (P)Tyrs are also on the market. Most of the currently available anti-(P)Tyrs bind free (P)Tyr quite well--with affinities in the µM range or better. Cross-reaction with phosphoserine and phosphothreonine [(P)Ser and (P)Thr] is not generally a problem with these immunoreagents, but monoclonal anti- bodies generated in some of the early efforts can bind to nucleotides and (P)His. For a review of commercially available anti-(P)Tyr reagents and kits that contain them, read on.


Immunohistochemical staining with mAb 4G10. Image provided by Upstate Biotechnology.

In the 1980s, different research groups were trying out various antigens for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies